Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Cboe BZX
09:52:15 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 42.78 USD | +0.41% |
|
-2.79% | -55.03% |
| Market Cap | 6.17TCr 5.51TCr 5.13TCr 4.67TCr 8.79TCr 5,94600Cr 8.86TCr 62TCr 24TCr 3,03500Cr 23TCr 23TCr 9,75400Cr | P/E 2026 * |
16.1x | P/E 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 7.05TCr 6.29TCr 5.86TCr 5.33TCr 10TCr 6,78600Cr 10TCr 71TCr 28TCr 3,46400Cr 26TCr 26TCr 11,13300Cr | EV / Sales 2026 * |
3.32x | EV / Sales 2027 * | 3.02x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Tradegate
| BSX | Real-time | |
|
London S.E.
| 0HOY | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.40% | ||
| 1 week | -2.79% | ||
| Current month | -1.76% | ||
| 1 month | -4.67% | ||
| 3 months | -3.86% | ||
| 6 months | -31.49% | ||
| Current year | -55.03% |
| 1 week | 41.94 |  | 44.3 |
| 1 month | 41.94 | | 47.45 |
| Current year | 41.94 | | 100.9 |
| 1 year | 41.94 | | 105.65 |
| 3 years | 41.94 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.41% | -2.79% | -55.66% | -17.03% | 6.17TCr | |
| +1.91% | -1.83% | +22.47% | +33.76% | 24TCr | |
| +2.08% | -4.01% | +3.07% | +0.62% | 15TCr | |
| +3.26% | -2.72% | -10.27% | +39.10% | 14TCr | |
| +2.24% | +0.21% | +13.65% | +20.51% | 4.91TCr | |
| -1.08% | -3.15% | -22.50% | -21.55% | 4.74TCr | |
| +1.56% | -3.15% | +19.83% | +53.77% | 4.73TCr | |
| +1.00% | -0.92% | -7.46% | +37.73% | 4.43TCr | |
| +2.29% | -2.23% | +32.18% | +62.80% | 4.18TCr | |
| +4.23% | +4.13% | +180.26% | +103.06% | 4.12TCr | |
| Average | +1.76% | -2.14% | +17.56% | +31.28% | 8.64TCr | |
| Weighted average by Cap. | +1.95% | -2.78% | +11.61% | +27.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.12TCr 1.89TCr 1.76TCr 1.6TCr 3.02TCr 2,04100Cr 3.04TCr 21TCr 8.28TCr 1,04200Cr 7.96TCr 7.79TCr 3,34900Cr | 2.22TCr 1.98TCr 1.85TCr 1.68TCr 3.17TCr 2,14200Cr 3.19TCr 22TCr 8.69TCr 1,09300Cr 8.35TCr 8.17TCr 3,51400Cr |
| Net income | 378.75Cr 337.88Cr 314.78Cr 286.47Cr 539.47Cr 36TCr 543.46Cr 3.8TCr 1.48TCr 19TCr 1.42TCr 1.39TCr 60TCr | 366.97Cr 327.38Cr 305Cr 277.56Cr 522.7Cr 35TCr 526.57Cr 3.69TCr 1.43TCr 18TCr 1.38TCr 1.35TCr 58TCr |
| Net Debt | 872.8Cr 778.63Cr 725.4Cr 660.14Cr 1.24TCr 84TCr 1.25TCr 8.77TCr 3.41TCr 43TCr 3.28TCr 3.21TCr 1,37900Cr | 549.48Cr 490.19Cr 456.69Cr 415.6Cr 782.66Cr 53TCr 788.46Cr 5.52TCr 2.15TCr 27TCr 2.06TCr 2.02TCr 87TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | $42.89 | +0.67% | 38,32,741 |
| 02/26/02 | $42.60 | -1.46% | 1,83,13,943 |
| 01/26/01 | $43.23 | -0.96% | 1,79,37,780 |
| 30/26/30 | $43.65 | -0.52% | 1,79,67,900 |
| 29/26/29 | $43.88 | -0.52% | 1,46,05,116 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
